Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and Lapatinib.

Andrea Sartore-Bianchi,Sara Lonardi,Massimo Aglietta,Cosimo Martino,Fortunato Ciardiello,Silvia Marsoni,Salvatore Siena

Central Nervous System as Possible Site of Relapse in ERBB2-Positive Metastatic Colorectal Cancer: Long-term Results of Treatment With Trastuzumab and Lapatinib.

2020

Andrea Sartore-Bianchi
Sara Lonardi
Massimo Aglietta
Cosimo Martino
Fortunato Ciardiello
Silvia Marsoni
Salvatore Siena

This secondary analysis of data from the HERACLES-A clinical trial examines long-term outcomes in 32 patients with colorectal cancer treated with trastuzumab and lapatinib.

Keywords:

long term results
Trastuzumab
Central nervous system
Oncology
Lapatinib
Colorectal cancer
ERBB2 Positive
Medicine
Internal medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations